title: Dopamine potentiation of calcium ionophore, A-23187-induced platelet aggregation.
authors.affiliation: Department of Physiology and Pharmacology, Aga Khan University, Karachi, Pakistan.
authors.forename: B H
authors.initials: BH
authors.lastname: Shah
authors.forename: S A
authors.initials: SA
authors.lastname: Saeed
authors.forename: F
authors.initials: F
authors.lastname: Rashid
authors.forename: A H
authors.initials: AH
authors.lastname: Gilani
mesh_terms: D015102:3,4-Dihydroxyphenylacetic Acid / Q000494:pharmacology; D000470:Alkaloids; D000730:Androstadienes / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D053119:Benzophenanthridines; D000001:Calcimycin / Q000494:pharmacology*; D002118:Calcium / Q000502:physiology; D002746:Chlorpromazine / Q000494:pharmacology; D004110:Diltiazem / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D019204:GTP-Binding Proteins / Q000502:physiology; D006220:Haloperidol / Q000494:pharmacology; D006719:Homovanillic Acid / Q000494:pharmacology; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D017136:Ion Transport / Q000187:drug effects; D007476:Ionophores / Q000494:pharmacology*; D010617:Phenanthridines / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D019869:Phosphatidylinositol 3-Kinases / Q000502:physiology; D000081082:Phosphoinositide-3 Kinase Inhibitors; D010974:Platelet Aggregation / Q000187:drug effects*; D011433:Propranolol / Q000494:pharmacology; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000502:physiology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000502:physiology; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology; D012701:Serotonin / Q000031:analogs & derivatives / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects; D014700:Verapamil / Q000494:pharmacology; D000077191:Wortmannin
chemical_list: D015102:3,4-Dihydroxyphenylacetic Acid; D000470:Alkaloids; D000730:Androstadienes; D001241:Aspirin; D053119:Benzophenanthridines; D000001:Calcimycin; D002118:Calcium; D002746:Chlorpromazine; D004110:Diltiazem; D004298:Dopamine; D004791:Enzyme Inhibitors; D019204:GTP-Binding Proteins; D006220:Haloperidol; D006719:Homovanillic Acid; D007213:Indomethacin; D007476:Ionophores; D010617:Phenanthridines; D010646:Phentolamine; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011433:Propranolol; D011493:Protein Kinase C; D011505:Protein-Tyrosine Kinases; D011954:Receptors, Dopamine; D012701:Serotonin; D014700:Verapamil; D000077191:Wortmannin; C027803:6-hydroxytryptamine; C016299:chelerythrine